Literature DB >> 16191354

[Effect of doxycycline on inflammation-related cytokines and apoptosis in human conjunctival epithelial cells].

Qi-guo Xiao1, Zu-guo Liu, Mei Zhang, Jian-liang Zheng, Zhi-hong Zhang, Li-hui Luo, Jia-qi Chen.   

Abstract

OBJECTIVE: To evaluate the effects of doxycycline on the regulation of intercellular adhesion molecule-1 (ICAM-1, CD54), interleukin-1beta (IL-1beta), human leukocyte antigen DR (HLA-DR) and apoptosis in human conjunctival epithelial cells.
METHODS: Human primary conjunctival epithelial cells were isolated and cultured from donors and identified by immunohistochemistry. Cultured epithelial cells were treated with either 0 U/ml IFN-gamma, 300 U/ml IFN-gamma, 300 U/ml IFN-gamma with 10 microg/ml doxycycline, 300 U/ml IFN-gamma with 20 microg/ml doxycycline, 300 U/ml IFN-gamma with 40 microg/ml doxycycline or 300 U/ml IFN-gamma with 100 microg/ml dexamethasone for 24 hours. The amount of CD54, HLA-DR and IL-1beta was measured by flow cytometry and western blot analysis. Apoptosis was evaluated by flow cytometry after the cultured epithelial cells were treated for 72 hours.
RESULTS: Cultured conjunctival epithelial cells can express CD54 and IL-1beta. IFN-gamma increased the amount of CD54 and IL-1beta (P < 0.01). Doxycycline and dexamethasone inhibited the IFN-gamma induced increase of express of CD54 and IL-1beta of cultured conjunctival epithelial cells, and the inhibiting effect was dependent on the concentration of doxycycline (P < 0.01). Very little HLA-DR and apoptosis were detected before and after treatment with IFN-gamma.
CONCLUSION: Doxycycline can suppress the expression of inflammatory cytokine such as CD54 and IL-1beta, which suggests that doxycycline may be a potent drug for the treatment of ocular surface inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191354

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  2 in total

1.  Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study.

Authors:  Liz M Leite; Antônio Germano G Carvalho; Pollyanna L F Tavares Ferreira; Igor Xavier Pessoa; Danilo O Gonçalves; Amanda de Araújo Lopes; Jean Guilherme dos Santos Góes; Victor Costa de Castro Alves; Luzia Kalyne A M Leal; Gerly Anne Brito; Glauce S B Viana
Journal:  Inflammopharmacology       Date:  2011-02-25       Impact factor: 4.473

2.  Protective effects of doxycycline in ischemia/reperfusion injury on kidney.

Authors:  A Kucuk; S Kabadere; M Tosun; T Koken; M K Kinaci; B Isikli; N Erkasap
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.